Want to see GB:CRTA full AI Analyst Report?
Cirata (CRTA) AI Stock Analysis
Top Page
Cirata
(LSE:CRTA)
The score is held down primarily by weak financial quality (ongoing losses and continued cash burn) and bearish technicals (below major moving averages with negative MACD). Partially offsetting these are attractive valuation (low P/E) and a constructive earnings-call outlook focused on reaching FY2026 cash flow breakeven, supported by pipeline growth and IBM-related progress, though new-logo execution remains a key near-term risk.
Cirata (CRTA) vs. iShares MSCI United Kingdom ETF (EWC)
- Market Cap
- GBP 6.76M
- Dividend Yield
- ―
- Average Volume (3M)
- 411.22K
- Price to Earnings (P/E)
- 3.6
- Beta (1Y)
- 0.20
- Revenue Growth
- 24.57%
- EPS Growth
- ―
- Country
- UK
- Employees
- 69
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Software - Application
Cirata Business Overview & Revenue Model
Company Description
Operating internationally across North America, Europe, and China, Cirata plc – previously known as WANdisco plc until its rebranding in October 2023 – specializes in creating and supplying collaboration software. A central offering is its WANdisco D...
How the Company Makes Money
Cirata primarily makes money by selling enterprise software subscriptions and related commercial offerings around its data flow and data management products (notably its enterprise distribution of Apache NiFi and associated management/governance capa...
Cirata Earnings Call Summary
The call was predominantly positive, supported by an oversubscribed $7.2 million fundraise, a 40% pipeline increase to GBP 21 million ACV, full go-to-market staffing, the first live Symphony deployment, IBM OEM validation, disciplined overheads, and reaffirmed FY 2026 cash flow breakeven guidance. The main setbacks were the lack of new-logo wins in Q2, GBP 2.1 million of net cash consumption, and the acknowledged need to improve product messaging.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management reaffirmed its outlook to target cash flow breakeven for FY 2026, with total overheads at GBP 3.2 million in Q2 consistent with the FY 2026 annualized range between GBP 12 million and GBP 13 million, representing a reduction of over 70% from the peak; the second-half goal is to execute with focus, convert the pipeline into new customer wins, and demonstrate that a fully resourced go-to-market organization can deliver new customer acquisition and scale building on the FY 2025 growth trajectory, with new logo conversion expected to show up as the year progresses.
Cirata Financial Statement Overview
Summary
Revenue growth accelerated sharply in 2025 (~63% YoY) and gross margins remain exceptionally strong (~90%+), but profitability is still materially negative and operating losses persist. Cash flow remains a key weakness with negative operating and free cash flow (about -8.3M FCF in 2025), despite improvement vs 2024. Balance sheet leverage is low, but sustained losses have eroded equity over time.
Income Statement
46NeutralBalance Sheet
62PositiveCash Flow
34Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.85M | 12.12M | 7.68M | 6.70M | 9.69M | 7.31M |
| Gross Profit | 9.00M | 11.18M | 7.14M | 6.06M | 8.99M | 6.65M |
| EBITDA | -5.26M | -4.75M | -14.39M | -36.69M | -34.73M | -32.47M |
| Net Income | 2.51M | -7.26M | -13.51M | -36.48M | -29.61M | -37.59M |
Balance Sheet | ||||||
| Total Assets | 7.77M | 13.34M | 14.92M | 23.11M | 26.54M | 42.19M |
| Cash, Cash Equivalents and Short-Term Investments | 2.56M | 3.98M | 9.73M | 18.25M | 19.11M | 27.76M |
| Total Debt | 309.00K | 467.17K | 889.00K | 795.00K | 539.00K | 1.82M |
| Total Liabilities | 2.04M | 3.10M | 5.35M | 6.50M | 8.64M | 7.76M |
| Stockholders Equity | 5.73M | 10.24M | 9.57M | 16.61M | 16.56M | 34.42M |
Cash Flow | ||||||
| Free Cash Flow | -5.85M | -8.35M | -14.88M | -30.67M | -27.70M | -34.00M |
| Operating Cash Flow | -5.79M | -8.26M | -14.77M | -30.60M | -27.50M | -28.23M |
| Investing Cash Flow | 2.91M | 2.93M | -107.00K | -43.00K | -158.00K | -5.76M |
| Financing Cash Flow | -494.91K | -575.83K | 6.44M | 29.10M | 19.48M | 40.79M |
Cirata Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CRTA, the sentiment is Negative. The current price of 5.35 is below the 20-day moving average (MA) of 6.54, below the 50-day MA of 8.78, and below the 200-day MA of 14.90, indicating a bearish trend. The MACD of -0.98 indicates Negative momentum. The RSI at 33.64 is Neutral, neither overbought nor oversold. The STOCH value of 45.84 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:CRTA.
Cirata Peers Comparison
Overall Rating
GB:ELCO74Outperform
GB:NET70Outperform
GB:ACSO65Neutral
GB:DOTD64Neutral
GB:AOM56Neutral
GB:CRTA50Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 74Outperform | GBP 194.94M | 50.33 | 11.31% | 0.52% | 16.89% | 2.68% | |
| 70Outperform | GBP 219.22M | 138.17 | 3.23% | 0.73% | 20.24% | -62.04% | |
| 65Neutral | GBP 102.04M | 15.59 | 5.35% | ― | -1.05% | -2.05% | |
| 64Neutral | GBP 156.31M | 17.11 | 8.80% | 2.35% | 3.82% | -18.43% | |
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
| 56Neutral | GBP 66.39M | -19.13 | -26.19% | ― | 47.75% | -308.39% | |
| 50Neutral | GBP 8.71M | 3.60 | 31.47% | ― | 24.57% | ― |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| GB:CRTA | Cirata Plc | 5.35 | -13.30 | -71.31% | |
| GB:ACSO | accesso Technology | 315.00 | -41.00 | -11.52% | |
| GB:DOTD | Dotdigital Group plc | 51.50 | -15.26 | -22.86% | |
| GB:ELCO | Eleco Plc | 231.00 | 76.59 | 49.60% | |
| GB:NET | Netcall plc | 128.50 | 3.57 | 2.86% | |
| GB:AOM | ActiveOps plc | 92.50 | -122.50 | -56.98% |
Cirata Corporate Events
Cirata banks on Q4 enterprise wins after modest Q3 and strengthened cash position
NeutralCirata plc reported a broadly stable third quarter, with annual contract value slipping marginally to $5.2 million and billings of $1.3 million, while remaining contract billings declined to $4.4 million. There was no net new ACV, reflecting the expi...
Cirata Confirms Total Voting Rights at 162.8 Million Shares
NeutralCirata plc reported that its issued share capital as of 24 September 2026 consists of 162,761,226 ordinary shares of ten pence each, all carrying voting rights and admitted to trading under ISIN JE00B6Y3DV84 with ticker CRTA. The company holds no sha...
Cirata’s revenue slides as contract delays push back cash-flow breakeven goal
NegativeCirata has reported a steep year-on-year drop in interim revenue to $1.0 million and a wider adjusted EBITDA loss, reflecting lumpy enterprise sales and delayed contract closures despite modest growth in annual contract value. The company nevertheles...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 29, 2026